Literature DB >> 2849509

Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.

M Green1, P M Loewenstein.   

Abstract

HIV-1 encodes a potent trans-activator protein, tat, which is essential for viral gene expression. To study tat domains that function in trans-activation, we chemically synthesized the 86 amino acid tat protein (tat-86) and tat mutant peptides. Remarkably, tat-86 is rapidly taken up by cells, and produces a massive and specific stimulation of HIV-LTR-driven RNA synthesis. Mutant peptides of 21 to 41 amino acids exhibit significant activity. Only two regions are essential for trans-activation; we suggest that one represents an activation region and the other, a nucleic acid binding or nuclear targeting region. Amino acid substitutions within these regions greatly reduce trans-activation, demonstrating the functional significance of these domains. The N-terminal 37 amino acids and exon 2 are not essential. Thus, tat is similar to regulatory proteins of Ad E1A and BPV1 E5 oncogenes, requiring only small domains for autonomous function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849509     DOI: 10.1016/0092-8674(88)90262-0

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  378 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

2.  Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.

Authors:  Z Lai; I Han; G Zirzow; R O Brady; J Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors.

Authors:  V P Torchilin; R Rammohan; V Weissig; T S Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 4.  Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.

Authors:  Ganna Bilousova; Dennis R Roop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

5.  Quantitative ratiometric discrimination between noncancerous and cancerous prostate cells based on neuropilin-1 overexpression.

Authors:  Alessia Pallaoro; Gary B Braun; Martin Moskovits
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

6.  Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cell-penetrating peptide domain: involvement of internalization in the in vivo role of exogenous FGF12.

Authors:  Fumiaki Nakayama; Takeshi Yasuda; Sachiko Umeda; Masahiro Asada; Toru Imamura; Viktor Meineke; Makoto Akashi
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

7.  Control of siRNA expression using the Cre-loxP recombination system.

Authors:  Vivi Kasim; Makoto Miyagishi; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

Review 8.  Cell penetrating peptides in drug delivery.

Authors:  Eric L Snyder; Steven F Dowdy
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

9.  Antimicrobial peptides and induced membrane curvature: geometry, coordination chemistry, and molecular engineering.

Authors:  Nathan W Schmidt; Gerard C L Wong
Journal:  Curr Opin Solid State Mater Sci       Date:  2013-08       Impact factor: 11.354

10.  The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.

Authors:  Bruno P Meloni; Amanda J Craig; Nadia Milech; Richard M Hopkins; Paul M Watt; Neville W Knuckey
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.